Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
QuintilesIMS
Moodys
Teva
Queensland Health
Medtronic
Baxter
Harvard Business School
Farmers Insurance

Generated: June 18, 2018

DrugPatentWatch Database Preview

TARO Company Profile

« Back to Dashboard

Summary for TARO
International Patents:62
US Patents:10
Tradenames:111
Ingredients:94
NDAs:213
Patent Litigation for TARO: See patent lawsuits for TARO
PTAB Cases with TARO as petitioner: See PTAB cases with TARO as petitioner

Drugs and US Patents for TARO

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro CLOBETASOL PROPIONATE clobetasol propionate GEL;TOPICAL 075279-001 May 28, 1999 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Taro Pharm Inds CICLOPIROX ciclopirox SOLUTION;TOPICAL 078144-001 Sep 18, 2007 AT RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Taro FLUCONAZOLE fluconazole TABLET;ORAL 076507-004 Jul 29, 2004 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Taro Pharm BETAMETHASONE VALERATE betamethasone valerate AEROSOL, FOAM;TOPICAL 208204-001 May 24, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for TARO

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Taro FLO-PRED prednisolone acetate SUSPENSION;ORAL 022067-001 Jan 17, 2008 6,399,079 ➤ Try a Free Trial
Taro FLO-PRED prednisolone acetate SUSPENSION;ORAL 022067-001 Jan 17, 2008 5,881,926 ➤ Try a Free Trial
Taro FLO-PRED prednisolone acetate SUSPENSION;ORAL 022067-001 Jan 17, 2008 6,656,482 ➤ Try a Free Trial
Taro FLO-PRED prednisolone acetate SUSPENSION;ORAL 022067-001 Jan 17, 2008 6,102,254 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for TARO drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Topical Lotion 0.5% ➤ Subscribe 2011-03-16
➤ Subscribe Topical Spray 0.25% ➤ Subscribe 2013-12-18
Premature patent expirations for TARO

Expiration due to failure to pay maintenance fee

Patent Number Expiration Date
➤ Try a Free Trial ➤ Try a Free Trial

Non-Orange Book US Patents for TARO

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,536,155 Process for preparing malathion for pharmaceutical use ➤ Try a Free Trial
8,957,238 Process for preparing malathion for pharmaceutical use ➤ Try a Free Trial
5,886,038 Composition and method for treatment of psoriasis ➤ Try a Free Trial
8,039,657 Process for preparing malathion for pharmaceutical use ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Supplementary Protection Certificates for TARO Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
00085 Netherlands ➤ Try a Free Trial PRODUCT NAME: LEVOCETIRIZINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER LEVOCETIRINE DIHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 26770 20011009; FIRST REGISTRATION: DE 49903.00.00 AND 49904.00.00 20010103
C0021 Belgium ➤ Try a Free Trial PRODUCT NAME: LANSOPRAZOLE + CLARITHROMYCINE + METRONIDAZOLE; REGISTRATION NO/DATE IN FRANCE: K 27 17033R DU 19960209; REGISTRATION NO/DATE AT EEC: K 27 17033R DU 19960209
C0042 Belgium ➤ Try a Free Trial PRODUCT NAME: 2-(2-BENZOYL-SUBSTITUE)-1,3-CYCLOHEXANE-DIONES; REGISTRATION NO/DATE: 8452/B 19930121
C0076 France ➤ Try a Free Trial PRODUCT NAME: SIMEPREVIR OU L'UN DE SES SELS, INCLUANT LE SEL DE SODIUM DE SIMEPREVIR; REGISTRATION NO/DATE: EU/1/14/924 20140514
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Cantor Fitzgerald
Farmers Insurance
Fuji
Express Scripts
Dow
Baxter
Chinese Patent Office
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.